Search research articles
Contact Us
Filters
Showing results (71-80 of 177) with videos related to
Page
of 18
Sort By:
Advances in Therapy
|
May 6, 2025
One-Year Efficacy of Guselkumab Versus Advanced Therapies for the Treatment of Moderately to Severely Active Crohn's Disease: A Network Meta-Analysis
Tim Disher, Dominik Naessens, Myrlene Sanon, et al.
BMJ Open Gastroenterology
|
May 31, 2016
Effectiveness of budesonide MMX (Cortiment) for the treatment of mild-to-moderate active ulcerative colitis: study protocol for a prospective multicentre observational cohort study
Silvio Danese, Ailsa Hart, Axel Dignass, et al.
World Journal of Gastroenterology
|
January 27, 2006
Open label trial of granulocyte apheresis suggests therapeutic efficacy in chronically active steroid refractory ulcerative colitis
Wolfgang Kruis, Axel Dignass, Elisabeth Steinhagen-Thiessen, et al.
Journal of Gastroenterology
|
June 6, 2018
Systematic review with meta-analysis: real-world effectiveness and safety of vedolizumab in patients with inflammatory bowel disease
Stefan Schreiber, Axel Dignass, Laurent Peyrin-Biroulet, et al.
Journal of Crohn'S & Colitis
|
December 3, 2010
European evidenced-based consensus on reproduction in inflammatory bowel disease
C Janneke van der Woude, Sanja Kolacek, Iris Dotan, et al.
Zeitschrift Fur Gastroenterologie
|
April 10, 2024
[Update: Addendum to S3-Guidelines Crohn disease and ulcerative colitis: Management of Patients with Inflammatory Bowel Disease with regard to COVID-19 (version 2.0)]
Carsten Schmidt, Andreas Stallmach, Andreas Sturm, et al.
Inflammatory Bowel Diseases
|
October 17, 2022
Impact of Crohn's Disease Therapies on Histology in Randomized Controlled Trials: Systematic Review With Meta-analysis
Joana Roseira, Mafalda Santiago, Maria Manuela Estevinho, et al.
United European Gastroenterology Journal
|
January 29, 2025
Inadequate Therapy Response on Advanced Therapy in Ulcerative Colitis Adult Patients: A Retrospective Analysis of German Health Claims Data
Axel Dignass, Irina Blumenstein, Carolina Schwedhelm, et al.
Inflammatory Bowel Diseases
|
July 31, 2024
Mucosal and Transmural Healing and Long-term Outcomes in Crohn's Disease
Bruce E Sands, Silvio Danese, J Casey Chapman, et al.
United European Gastroenterology Journal
|
November 9, 2019
A multicentre prospective cohort study assessing the effectiveness of budesonide MMX® (Cortiment®<sup>MMX®</sup>) for active, mild-to-moderate ulcerative colitis
Silvio Danese, Ailsa Hart, Axel Dignass, et al.
Page
of 18
Search research articles
Search
Showing results (71-80 of 177) with videos related to
Sort By:
Page
of 18
Advances in Therapy
|
May 6, 2025
One-Year Efficacy of Guselkumab Versus Advanced Therapies for the Treatment of Moderately to Severely Active Crohn's Disease: A Network Meta-Analysis
Tim Disher, Dominik Naessens, Myrlene Sanon, et al.
BMJ Open Gastroenterology
|
May 31, 2016
Effectiveness of budesonide MMX (Cortiment) for the treatment of mild-to-moderate active ulcerative colitis: study protocol for a prospective multicentre observational cohort study
Silvio Danese, Ailsa Hart, Axel Dignass, et al.
World Journal of Gastroenterology
|
January 27, 2006
Open label trial of granulocyte apheresis suggests therapeutic efficacy in chronically active steroid refractory ulcerative colitis
Wolfgang Kruis, Axel Dignass, Elisabeth Steinhagen-Thiessen, et al.
Journal of Gastroenterology
|
June 6, 2018
Systematic review with meta-analysis: real-world effectiveness and safety of vedolizumab in patients with inflammatory bowel disease
Stefan Schreiber, Axel Dignass, Laurent Peyrin-Biroulet, et al.
Journal of Crohn'S & Colitis
|
December 3, 2010
European evidenced-based consensus on reproduction in inflammatory bowel disease
C Janneke van der Woude, Sanja Kolacek, Iris Dotan, et al.
Zeitschrift Fur Gastroenterologie
|
April 10, 2024
[Update: Addendum to S3-Guidelines Crohn disease and ulcerative colitis: Management of Patients with Inflammatory Bowel Disease with regard to COVID-19 (version 2.0)]
Carsten Schmidt, Andreas Stallmach, Andreas Sturm, et al.
Inflammatory Bowel Diseases
|
October 17, 2022
Impact of Crohn's Disease Therapies on Histology in Randomized Controlled Trials: Systematic Review With Meta-analysis
Joana Roseira, Mafalda Santiago, Maria Manuela Estevinho, et al.
United European Gastroenterology Journal
|
January 29, 2025
Inadequate Therapy Response on Advanced Therapy in Ulcerative Colitis Adult Patients: A Retrospective Analysis of German Health Claims Data
Axel Dignass, Irina Blumenstein, Carolina Schwedhelm, et al.
Inflammatory Bowel Diseases
|
July 31, 2024
Mucosal and Transmural Healing and Long-term Outcomes in Crohn's Disease
Bruce E Sands, Silvio Danese, J Casey Chapman, et al.
United European Gastroenterology Journal
|
November 9, 2019
A multicentre prospective cohort study assessing the effectiveness of budesonide MMX® (Cortiment®<sup>MMX®</sup>) for active, mild-to-moderate ulcerative colitis
Silvio Danese, Ailsa Hart, Axel Dignass, et al.
Page
of 18